Top Banner

of 25

GDS. K.13a. Neonatal Sepsis

Apr 05, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    1/25

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    2/25

    2

    Direct Causes of Neonatal DeathsWorld Health Organization. State of the Worlds Newborns 2001

    Infections 32%

    Asphyxia 29% Complications of prematurity 24%

    Congenital anomalies 10%

    Other 5%

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    3/25

    3

    Definition

    Neonatal sepsis is a clinical syndrome

    Of systemic illness accompanied by

    bacteremia occurring in the first monthof life

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    4/25

    4

    Early Onset

    < 72 hours of ageAcquired around birth

    Vertical transmission

    from mother to baby

    Late Onset

    > 72 hours of ageAcquired from the

    environment

    Nosocomial or

    hospital acquired

    Distinction between Early onset sepsis and Late onset sepsisnot clear in developing countries:

    baby born at home and brought to the hospital at 3 days of age baby referred from another hospital

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    5/25

    5

    Early Onset Sepsis - risk factors

    Prolonged rupture of

    membranes >18 h

    Maternal chorioamnionitis

    Foul smelling amniotic fluid

    Handling by untrained midwife

    Maternal urinary tract infection

    Premature labor

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    6/25

    6

    Late Onset Sepsis -

    risk factors

    Prematurity/ LBW

    In hospital

    Invasive procedures- ventilator, IV lines,central lines, urine catheter, chest tube

    Contact with infectious disease - doctors,

    nurses, babies with infections,

    Not fed maternal breast milk

    POOR HYGIENE in NICU

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    7/25

    7

    Bacterial Pathogens Responsible for Sepsis

    in Developing Countries

    Early onset sepsis

    Gram negative

    bacilliE.coli Klebsiella

    Enterococcus

    Group B

    streptococcus

    Late onset sepsis

    Gram negative

    bacilliPseudomonasKlebsiella

    Staph aureus

    Coagulase negative

    staphylococci

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    8/25

    8

    Diagnosis of Neonatal Sepsis

    Clinical signs and symptoms

    Laboratory tests

    culture of bacterial pathogen

    other laboratory indicators

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    9/25

    9

    Diagnosis of Neonatal Sepsis -clinical signs and symptoms

    Clinical Signs: early signs non- specific, may besubtleRespiratory distress- 90%ApneaTemperature instability- temp more commonDecreased activity IrritabilityPoor feedingAbdominal distensionHypotension, shock, purpura, seizures-late

    signs

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    10/25

    10

    Purpura

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    11/25

    11

    Pseudomonas sepsis with DIC

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    12/25

    12

    Laboratory Tests

    Cultures to identify bacterial pathogenblood, csf, urine, other

    Hematological testsWBC count

    Platelet count

    Erythrocyte Sedimentation Rate (ESR)

    Other testsC- reactive protein

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    13/25

    13

    Abnormal white blood cell count

    Total WBC count < 5000 /L, > 25, 000/L

    Absolute neutrophil count: 0.2 Immature to mature neutrophil ratio > 0.2

    bandform

    neutrophil

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    14/25

    14

    Chest X Ray

    Group B streptococcal sepsis:

    diffuse ground glass opacity indistinguishablefrom HMD

    Persistent focal parenchymal lung findings

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    15/25

    15

    Group B Strep

    Pneumonia

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    16/25

    16

    First line therapy in facility setting(WHO 2003)

    Ampicillin 50 mg/ kgevery 12 hours in 1st week of life

    every 8 hours from 2- 4 weeksPLUSGentamicin> usia kehamilan 35 minggu: 4 mg / kg setiap

    24 jamusia kehamilan 30 - 34 minggu:

    0 - 7 hari: 4.5 mg/kg setiap 36 jam

    > 8 hari: 4 mg/kg setiap 24 jam

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    17/25

    17

    Suspected Staphylococcal Infection

    Use Cloxacillin or flucloxacillin instead ofAmpicillin.

    Plus gentamicin

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    18/25

    18

    Baby not responding to first line antibiotics

    or suspected hospital acquired infection

    3rd generation cephalosporin

    cefotaxime

    ceftazidime

    For nosocomial infection :

    vancomycin plus gentamicin/

    amikacin or ceftazidime

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    19/25

    19

    Treatment of Fungal Infection

    Amphotericin B

    Intravenous infusionfor 14 to 21 days

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    20/25

    20

    Duration of antibiotic treatmentSepticemia

    Gram negative septicemia: 14 days

    Group B Strep septicemia: 10-14 days

    Repeat blood culture within 24 - 48 hours of

    beginning treatment to document clearance of

    organism.

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    21/25

    21

    Duration of antibiotic treatment

    Meningitis

    Gram negative meningitis: 21 days minimum

    Group B Strep meningitis: 14 - 21 days

    Document negative culture within 24 - 48 hours

    of beginning treatment

    Consider neuroimaging studies

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    22/25

    22

    Supportive Care

    Temperature support

    GI support - vomiting, ileus

    Cardiorespiratory support hypoxia, apnea, shock

    Hematological support: anemia,

    thrombocytopenia, DICNeurological support- seizures

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    23/25

    23

    Prevention of Nosocomial Infection

    Hand washing

    Early feeding

    Maternal breast milk

    Decrease use of broad spectrum antibiotics

    Decreased use of invasive procedures

    Proper sterilization procedures

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    24/25

    24

    Prevention of Sepsis

  • 8/2/2019 GDS. K.13a. Neonatal Sepsis

    25/25

    25